All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The Solid Organ Transplant is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

AASLD AST practice guidelines for liver transplantation candidate evaluation

By Amy Hopkins

Share:

Jul 15, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in liver transplantation.


Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the American Society of Transplantation (AST) for the evaluation of liver transplantation candidates were published in Hepatology by Dove et al. The guidelines were developed by a multidisciplinary writing group, aiming to provide an outline for assessing patients for liver transplantation. 

Key insights: Patients with chronic liver disease who experience a decompensating event or have acute-on-chronic liver failure (ACLF), acute liver failure (ALF), hepatocellular carcinoma (HCC), or cholangiocarcinoma (CCA) should be referred to a liver transplant (LT) center for evaluation conducted by a multidisciplinary team, provided they meet criteria. Patients with non-hepatic malignancies with liver involvement may also be considered for evaluation. Cardiac, pulmonary, physical function, infection risk, and psychosocial evaluation should take place as part of the LT center assessment to assess risk for complications and to identify areas for intervention. Cancer screening and consideration of contraindications are also recommended.  

Key learning: Patients referred to LT centers should be carefully evaluated to determine their eligibility for liver transplantation, taking into consideration individual risks. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content